{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:13:35Z","timestamp":1787066015651,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jiac.2024.05.009","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T19:24:28Z","timestamp":1717010668000},"page":"1228-1232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["High prevalence of hepatitis C virus among criminals in rehabilitation facilities in Japan"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4192-8150","authenticated-orcid":false,"given":"Masayuki","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.05.009_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/hepr.13503","article-title":"Japan society of hepatology guidelines for the management of hepatitis C virus infection: 2019 update","volume":"50","year":"2020","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jiac.2024.05.009_bib2","article-title":"Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: a systematic literature review and meta-analysis","volume":"18","author":"Zoratti","year":"2020","journal-title":"E. Clin. Med"},{"key":"10.1016\/j.jiac.2024.05.009_bib3","article-title":"Trends of global burden related to HBV and HCV from 1990 to 2019: an age-period-cohort analysis","volume":"95","author":"Wu","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiac.2024.05.009_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11524-015-9953-4","article-title":"A budget impact analysis of newly available hepatitis C therapeutics and the financial burden on a state correctional system","volume":"92","author":"Nguyen","year":"2015","journal-title":"J Urban Health"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2024.05.009_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1186\/s12879-017-2779-9","article-title":"Economic evaluation of HCV testing approaches in low and middle income countries","volume":"17","author":"Morgan","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2024.05.009_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002032","article-title":"Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis","volume":"13","author":"Iyengar","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.jiac.2024.05.009_bib7","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1093\/cid\/ciz701","article-title":"A call to action: HCV treatment of people who inject drugs in the United States","volume":"70","author":"Norton","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.05.009_bib8","article-title":"Psychosocial and criminological factors related to recidivism among Japanese criminals at criminal rehabilitation facilities","volume":"4","author":"Kishi","year":"2018","journal-title":"Cogent Soc Sci"},{"key":"10.1016\/j.jiac.2024.05.009_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102693","article-title":"Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting","volume":"77","author":"Lafferty","year":"2020","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.jiac.2024.05.009_bib10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/cid\/ciac246","article-title":"Hepatitis C virus reinfection following direct-acting antiviral treatment in the prison setting: the SToP-C study","volume":"75","author":"Carson","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.05.009_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/COH.0000000000000572","article-title":"Prisons: ignore them at our peril","volume":"14","author":"Kamarulzaman","year":"2019","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jiac.2024.05.009_bib12","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(16)00619-X","article-title":"Public health and international drug policy","volume":"387","author":"Csete","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2024.05.009_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/hepr.12897","article-title":"Current activities and future directions of comprehensive hepatitis control measures in Japan: the supportive role of the hepatitis information center in building a solid foundation","volume":"47","author":"Oza","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jiac.2024.05.009_bib14","article-title":"Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: a simulation study","volume":"22","author":"Tanaka","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jiac.2024.05.009_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/v14030482","article-title":"HCV elimination in central Europe with particular emphasis on microelimination in prisons","volume":"14","author":"Flisiak","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jiac.2024.05.009_bib16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/MCG.0b013e31818dd94c","article-title":"Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C","volume":"43","author":"Chew","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jiac.2024.05.009_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-138-3-200302040-00010","article-title":"Treatment of chronic hepatitis C in a state correctional facility","volume":"138","author":"Allen","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2024.05.009_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1086\/591707","article-title":"Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations","volume":"47","author":"Maru","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.05.009_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1572-0241.2004.30310.x","article-title":"Treatment of chronic hepatitis C virus in the Virginia department of corrections: can compliance overcome racial differences to response?","volume":"99","author":"Sterling","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jiac.2024.05.009_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000252782","article-title":"Changing trends in hepatitis C infection over the past 50 years in Japan","volume":"53","author":"Chung","year":"2010","journal-title":"Intervirology"},{"key":"10.1016\/j.jiac.2024.05.009_bib21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jgh3.12376","article-title":"High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use","volume":"23","author":"Tamori","year":"2020","journal-title":"JGH Open"},{"key":"10.1016\/j.jiac.2024.05.009_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jgh3.12855","article-title":"Risk factors for loss to follow\u2010up after the start of direct\u2010acting antiviral treatment for hepatitis C virus infection","volume":"7","author":"Kuwano","year":"2023","journal-title":"JGH Open"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24001417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24001417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T19:56:18Z","timestamp":1738698978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24001417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1341321X24001417"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.05.009","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High prevalence of hepatitis C virus among criminals in rehabilitation facilities in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}